コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 of infection- and drug-induced hemolysis and neonatal jaundice.
2 ty in addition to modulating the severity of neonatal jaundice.
3 acy of metalloporphyrins in the treatment of neonatal jaundice.
4 mesoporphyrin is useful in the treatment of neonatal jaundice.
5 ad to improved pharmaceutical treatments for neonatal jaundice.
6 is widely used in Asia to prevent and treat neonatal jaundice.
7 al deficit of CAR activity may contribute to neonatal jaundice.
8 utcomes in diabetes, cancer, infections, and neonatal jaundice.
10 One type in particular is associated with neonatal jaundice and circulation of bilirubin in blood
11 to the pediatric clinician-- immunizations, neonatal jaundice, and animal-induced injuries-are conci
14 of Pediatrics treatment recommendations for neonatal jaundice are based on age-specific total serum
15 ferences in the genetic variants involved in neonatal jaundice compared to those regulating bilirubin
17 was identified in an infant presenting with neonatal jaundice due to underlying biliary abnormalitie
19 fection-related mortality in the UK Biobank; neonatal jaundice in ALSPAC) and performed a phenomewide
22 o those related to prematurity (CP-Preterm), neonatal jaundice/kernicterus (CP-Kernicterus) and hypox
25 integrating Bf and BT into the management of neonatal jaundice may help move clinical practice from i
26 5-minute Apgar score, neonatal hypoglycemia, neonatal jaundice, neonatal respiratory distress, neonat
27 ques to create a novel tool for screening of neonatal jaundice (NNJ), which affects 60% of term and 8
28 ilbert's syndrome may play a greater role in neonatal jaundice, only help confirm that the story of n
29 al respiratory distress with NICU admission, neonatal jaundice or hyperbilirubinemia, neonatal hypogl
30 autosomal dominant disorder characterized by neonatal jaundice, paucity of intrahepatic bile ducts, a
31 ivery, maternal smoking during pregnancy, or neonatal jaundice predict islet autoimmunity in children
32 newborn's bilirubin levels, the indicator of neonatal jaundice risk, by 0.076 (95% CI: 0.027-0.125),
35 e, 25 female) had other documented causes of neonatal jaundice; the mean ages at US assessment were 4
36 t the first genome-wide association study of neonatal jaundice to date in nearly 30,000 parent-offspr
37 totherapy is a standard treatment for severe neonatal jaundice to remove toxic bilirubin from the blo
38 syndrome (adjusted HR, 2.43; 2.21-2.66), and neonatal jaundice was associated with more than a 50% in
39 experience suggests increased incidences of neonatal jaundice when air quality worsens, yet no studi
40 starvation has been suggested as a cause of neonatal jaundice, which can further cause permanent bra
41 e a convenient and efficient method to treat neonatal jaundice while allowing continuous breastfeedin